That’s why I Feel Comfortable With Edwards Lifesciences Corp’s (EW) Future

A share price of Edwards Lifesciences Corp [EW] is currently trading at $81.16, down -0.28%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The EW shares have gain 3.81% over the last week, with a monthly amount glided 5.53%, and seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

Edwards Lifesciences Corp [NYSE: EW] stock has seen the most recent analyst activity on July 29, 2025, when BTIG Research upgraded its rating to a Buy but kept the price target unchanged to $100 for it. Previously, Piper Sandler upgraded its rating to Overweight on April 24, 2025, and kept the price target unchanged to $80. On January 30, 2025, upgrade upgraded it’s rating to Buy and revised its price target to $90 on the stock. Wolfe Research downgraded its rating to a Underperform but stick to its price target of $60 on January 16, 2025. BofA Securities upgraded its rating to a Buy. In a note dated September 18, 2024, Jefferies downgraded an Hold rating on this stock and revised its target price from $85 to $70.

Edwards Lifesciences Corp experienced fluctuations in its stock price throughout the past year between $64.00 and $83.00. Currently, Wall Street analysts expect the stock to reach $75 within the next 12 months. Edwards Lifesciences Corp [NYSE: EW] shares were valued at $81.16 at the most recent close of the market. An investor can expect a potential drop of -7.59% based on the average EW price forecast.

Analyzing the EW fundamentals

Trailing Twelve Months sales for Edwards Lifesciences Corp [NYSE:EW] were 5.69B which represents 10.56% growth. Gross Profit Margin for this corporation currently stands at 0.79% with Operating Profit Margin at 0.26%, Pretax Profit Margin comes in at 0.29%, and Net Profit Margin reading is 0.73%. To continue investigating profitability, this company’s Return on Assets is posted at 0.31, Equity is 0.41 and Total Capital is 0.12. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.07.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 80.71 points at the first support level, and at 80.26 for the second support level. However, for the 1st resistance point, the stock is sitting at 81.93, and for the 2nd resistance point, it is at 82.71.

Ratios To Look Out For

To put it in perspective, the Current Ratio for Edwards Lifesciences Corp [NYSE:EW] is 4.68. Further, the Quick Ratio stands at 3.87, while the Cash Ratio is 2.33. Considering the valuation of this stock, the price to sales ratio is 8.38, the price to book ratio is 4.52 and price to earnings (TTM) ratio is 55.41.

Transactions by insiders

Recent insider trading involved Wood Larry L, Global President TAVR & Surg, that happened on Aug 18 ’25 when 8950.0 shares were sold. Officer, Wood Larry L completed a deal on Aug 18 ’25 to buy 8950.0 shares. Meanwhile, CVP, JAPAC Lippis Daniel J. sold 4114.0 shares on Jul 28 ’25.

Related Posts

MZP News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.